thrombocyte function after elective CABG with CPB
- Conditions
- platelet function (platjes functie), cardiac surgery (hart chirurgie), platelet function recovery (platejs funtcie herstel)
- Registration Number
- NL-OMON27232
- Lead Sponsor
- Maastricht University Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
elective patients scheduled for CABG
more than 250.00 thrombocyte/mcl
Exclusion Criteria
low thrombocyte count (below 250.000/mcl)
use of platelet inhibitors other tha aspirine
known thrombocytes dysfunction
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Multiple impedance electrode aggregometry (MEA- Multiplate multiple impedance aggregometry Dynabyte Medical, Munich, Germany), Light transmission aggregometry (LTA-platelet aggregometer PAR-4, Hart Biologicals Ltd., Hartlepool UK)
- Secondary Outcome Measures
Name Time Method Clinical parameters of bleeding (blood loss and transfusion requirements within the first 24 hours postoperative).